ACCEPTED MANUSCRIPT
9
1
4-(4-Methoxybenzyl)-1,1'-biphenyl (5w). Following the general
procedure, the crude residue was purified by column
chromatography on silica gel (eluted with petroleum ether : ethyl
acetate = 30:1 ) to afford 5i as a white solid (127 mg, 93%). m.p.
afford 6c as a colourless oil (106 mg, 95%). H NMR (400
MHz, CDCl3) δ 7.36-7.34 (m, 2H), 7.30-7.26 (m, 2H), 7.21-7.14
(m, 3H), 6.86-6.84 (m, 2H), 6.43 (d, J = 15.8 Hz, 1H), 6.33(dt, J
= 15.7, 6.5 Hz, 1H), 3.79 (s, 3H), 3.49 (d, J = 6.5 Hz, 2H); 13C
NMR (101 MHz, CDCl3) δ 158.1, 137.6, 132.2, 130.8, 129.7,
129.6, 128.5, 127.1, 126.2, 114.0, 55.3, 38.5.
1
83-86 ºC; IR (film) 1510, 1247, 1036, 750, 696, 652 cm-1; H
NMR (400 MHz, CDCl3) δ 7.56 (d, J = 7.6 Hz, 2H), 7.52-7.50
(m, 2H), 7.41 (t, J = 7.6 Hz, 2H), 7.33-7.30 (m, 1H), 7.25-7.23
(m, 2H), 7.14 (d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 3.96
(s, 2H), 3.79 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 158.1,
141.1, 140.7, 139.0, 133.1, 129.9, 129.2, 128.7, 127.2, 127.1,
127.0, 114.0, 55.3, 40.7; EI-MS (m/z, relative intensity) 274 (M+,
100), 272 (31), 243 (23), 197 (13), 165 (35), 121 (23), 77(11).
1-Methyl-4-(3-phenylprop-2-yn-1-yl)benzene and 1-methyl-3-(3-
phenylprop-2-yn-1-yl)benzene (3:1) (6d). Following the general
procedure, the crude residue was purified by column
chromatography on silica gel (eluted with petroleum ether) to
1
afford 6d as a colourless oil (96 mg, 93%). H NMR (400 MHz,
CDCl3) δ 7.45-7.42 (m, 2H), 7.31-7.27 (m, 4.5H), 7.32-7.31 (m,
0.8H), 7.14 (d, J = 7.9 Hz, 1.5H), 7.06-7.05 (m, 0.2H), 3.79 (s,
0.5H), 3.78 (s, 1.5H), 2.35 (s, 0.7H), 2.33 (s, 2.3H); 13C NMR
(101 MHz, CDCl3) δ 138.2 (minor), 136.7 (minor), 136.2, 133.7,
131.7, 129.2, 128.8 (minor), 128.5 (minor), 128.2, 127.9, 127.8,
127.4 (minor), 125.0 (minor), 123.8, 87.9, 87.7 (minor), 82.5
(minor), 82.5, 25.7 (minor), 25.4, 21.4 (minor), 21.1. The other
carbons of the minor product did not show on the 13C NMR
spectra due to the low concentration and limited scanning times.
Bis(4-methoxyphenyl)methane (5x).30 Following the general
procedure, the crude residue was purified by column
chromatography on silica gel (eluted with petroleum ether:ethyl
1
acetate = 30 : 1) to afford 5x as a white solid (104 mg, 91%): H
NMR (400 MHz, CDCl3) δ 7.08 (d, J = 8.6 Hz, 4H), 6.82 (d, J =
8.6 Hz, 4H), 3,86 (s, 2H), 3.76 (s, 6H); 13C NMR (101 MHz,
CDCl3) δ 157.9, 133.7, 129.7, 113.9, 55.3, 40.1.
1-(tert-Butyl)-4-(4-methoxybenzyl)benzene and 1-(tert-butyl)-3-
(4-methoxybenzyl) benzene (9:1) (5y). Following the general
procedure, the crude residue was purified by column
chromatography on silica gel (eluted with petroleum ether) to
1,2-Diphenylethane (6e).32 Following the general procedure, the
crude residue was purified by column chromatography on silica
gel (eluted with petroleum ether) to afford 6e as a white solid (30
1
1
afford pure 5y as a colorless oil (58 mg, 46%); H NMR (400
mg, 33%). H NMR (400 MHz, CDCl3) δ 7.22-7.18 (m, 4H),
MHz, CDCl3) δ 7.29 (d, J = 8.2 Hz, 2H), 7.12-7.09 (m, 4H),
6.84-6.81 (m, 2H), 3,92 (s, 0.2H), 3.89 (s, 1.8H), 3.77 (s, 3H),
1.29 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 157.9, 148.8, 138.6,
133.4, 129.9, 129.8 (minor), 128.4, 128.1 (minor), 125.9 (minor),
125.3, 113.9, 55.3, 41.3 (minor), 40.5, 34.4, 31.4, the other
carbons of the minor product shown no signal due to the low
concentration and limited scanning times; EI-MS (m/z, relative
intensity) 254 (M+, 42), 239 (100), 197 (21), 121 (46).
7.15-7.09 (m, 6H), 2.86 (s, 4H); 13C NMR (101 MHz, CDCl3) δ
141.8, 128.5, 128.3, 125.9, 37.9.
Acknowledgments
This project was supported by 973 program 2015CB856600) and
NSFC (Grant 21472004 and 21332002).
References and notes
1-(4-Methoxybenzyl)-3-nitrobenzene (5z).2e Following the general
procedure, the crude residue was purified by column
chromatography on silica gel (eluted with petroleum ether:ethyl
1. For reviews, see: (a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457-
2483; (b) Miyaura, N. Top. Curr. Chem. 2002, 219, 11-59; (c) Hassan, J.;
Sevignon, M.; Gozzi, C.; Schulz, E.; Lemaire, M. Chem. Rev. 2002, 58,
9633-9695; (d) Bellina, F.; Carpita, A.; Rossi, R. Synthesis 2004, 15,
2419-2440; (e) Martin, R.; Buchwald, S. L. Acc. Chem. Res. 2008, 41,
1461-1473; (f) Molander, G. A.; Canturk, B. Angew. Chem. Int. Ed. 2009,
48, 9240–9261; g) Suzuki, A. Angew. Chem. Int. Ed. 2011, 50, 6722-
6737.
2. (a) Langle, S.; Abarbri, M.; Duchene, A. Tetrahedron Lett. 2003, 44,
9255-9258; (b) Nobre, S. M.; Monteiro, A. L. Tetrahedron Lett. 2004, 45,
8225-8228; (c) Singh, R.; Viciu, M. S.; Kramareva, N.; Navarro, O.;
Nolan, S. P. Org. Lett. 2005, 7, 1829-1832; (d) Molander, G. A.; Elia, M.
D. J. Org. Chem. 2006, 71, 9198-9202; (e) Burns, M. J.; Fairlamb, I. J. S.;
Kapdi, A. R.; Sehnal, P.; Taylor, R. J. K. Org. Lett. 2007, 9, 5397-5400; (f)
Alacid, E.; Nájera, C. Org. Lett. 2008, 10, 5011-5014; (g) Zhang, Y.;
Feng, M.-T.; Lu, J.-M. Org. Biomol. Chem. 2013, 11, 2266-2272; (h)
Kuwano, R.; Yokogi, M. Org. Lett. 2005, 7, 945-947; (i) Yu, J.-Y.;
Kuwano, R. Org. Lett. 2008, 10, 973-976; (g) McLaughlin, M. Org. Lett.
2005, 7, 4875-4878.
3. For selected references, see: (a) Liégault, B.; Renaud, J.-L.; Bruneau, C.
Chem. Soc. Rev. 2008, 37, 290-299; (b) Long, Y.-Q.; Jiang, X.-H.; Dayam,
R.; Sachez, T.; Shoemaker, R.; Sei, S.; Neamati, N. J. Med. Chem. 2004,
47, 2561-2573; (c) Liégault, B.; Renaud, J.-L.; Bruneau, C. Chem. Soc.
Rev. 2008, 37, 290-299; (d) Washburn, W. N. J. Med. Chem. 2009, 52,
1785-1794; (e) Burley, S. D.; Lam, V. V.; Lakner, F. J.; Bergdahl, B. M.;
Parker, M. A. Org. Lett. 2013, 15, 2598-2600; (f) Ma, J.-C.; Dougherty, D.
A. Chem. Rev. 1997, 97, 1303-1324; (g) Conn, M. Rebek, M. J. Chem.
Rev. 1997, 97, 1647-1668.
4. For reviews, see: (a) Sun, C.-L.; Shi, Z.-J. Chem. Rev. 2014, 114, 9219-
9280; (b) Zhu, C.; Falck, J. R. Adv. Synth. Catal. 2014, 356, 2395-2410;
(c) Roscales, S.; Csákÿ, A. G. Chem. Soc. Rev. 2014, 43, 8215-8225.
5. (a) Leadbeater, N. E.; Marco, M. Angew. Chem. Int. Ed. 2003, 42, 1407-
1409; (b) Leadbeater, N. E.; Marco, M. J. Org. Chem. 2003, 68, 5660-
5667; (c) Arvela, R. K.; Leadbeater, N. E.; Sangi, M. S.; Williams, V. A.;
Granados, P.; Singer, R. D. J. Org. Chem. 2005, 70, 161-168.
1
acetate = 10:1) to afford 5z as a white solid (97 mg, 80%): H
NMR (400 MHz, CDCl3) δ 8.06-8.04 (m, 2H), 7.51-7.44 (m,
2H), 7.10 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 4.02 (s,
2H), 3.79 (s, 3H), 2.23 (s, 2.70H); 13C NMR (101 MHz, CDCl3) δ
158.4, 143.7, 135.0, 131.4, 129.9, 129.3, 123.6, 121.3, 114.2,
55.3, 40.6
1-Benzyl-3-nitrobenzene (6a).2e Following the general procedure,
the crude residue was purified by column chromatography on
silica gel (eluted with petroleum ether: ethyl acetate = 10:1) to
1
afford 6a as a white solid (51 mg, 48%). H NMR (400 MHz,
CDCl3) δ 8.07-7.05 (m, 2H), 7.51 (d, J = 7.6 Hz, 1H), 7.46-7.42
(m, 1H), 7.32 (t, J = 7.4 Hz, 2H), 7.26-7.24 (m, 1H), 7.18 (d, J =
7.3 Hz, 2H), 4.08 (s, 2H); 13C NMR (101 MHz, CDCl3) δ 148.5,
143.2, 139.4, 135.1, 129.4, 128.9, 128.8, 126.8, 123.7, 121.4,
41.5.
Methyl 4-benzylbenzoate (6b).2e Following the general procedure,
the crude residue was purified by column chromatography on
silica gel (eluted with petroleum ether) to afford pure 6b as a
1
colourless liquid (64 mg, 57%); H NMR (400 MHz, CDCl3) δ
7.96-7.94 (m, 2H), 7.31-7.21 (m, 5H), 7.18-7.16 (m, 2H), 4.02 (s,
2H), 3.89 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 167.1, 146.5,
140.1, 129.8, 129.0, 128.6, 128.1, 126.4, 52.0, 41.9.
1-Cinnamyl-4-methoxybenzene (6c).30 Following the general
procedure, the crude residue was purified by column
chromatography on silica gel (eluted with petroleum ether) to
6. Inamoto, K.; Hasegawa, C.; Hiroya, K.; Kondo, Y.; Osako, T.; Uozumi,